CoChat
Sign Up
Cited by 193Sepsis Diagnosis and TreatmentInflammation biomarkers and pathwaysAcute Kidney Injury Research

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

The clinical importance of a cytokine network in the acute phase of sepsis

Open access
Matsumoto, Hisatake, Ogura, Hiroshi, Shimizu, Kentaro, Ikeda, Mitsunori, Hirose, Tomoya, Matsuura, Hiroshi, Kang, Sujin, Takahashi, Kanae, Tanaka, Toshio, Shimazu, Takeshi·2018·Scientific Reports
DOI 10.1038/s41598-018-32275-8PMC PMC6143513
Open this paper in CoChat — free accountOpen PDF

Abstract

Sepsis remains a major cause of death. Cytokines interact closely with each other and play a crucial role in the progression of sepsis. We focussed on the associations of a cytokine network with prognosis and disease severities in sepsis. This retrospective study included 31 patients with sepsis and 13 healthy controls. Blood samples were collected from patients on days 1, 2, 4, 6, 8, 11 and 15 and from healthy controls. Levels of PAI-1, IFN-α, IFN-γ, IL-1β, IL-6, IL-8, IL-12/IL-23p40, IL-17A, TNF-α, MCP-1, IL-4 and IL-10 were measured. SOFA, JAAM DIC and ISTH DIC scores were evaluated at the same times blood samples were taken. Network analysis revealed a network formed by PAI-1, IL-6, IL-8, MCP-1 and IL-10 on days 1, 2 and 4 throughout the acute phase of sepsis. There were positive correlations of each cytokine and the combined score (IL-6 + IL-8 + IL-10 + MCP-1) with the SOFA, JAAM DIC and ISTH DIC scores throughout the acute phase. A Cox proportional hazards model focussed on the acute phase showed that the above combined score was significantly related with patient prognosis, suggesting that the cytokine network of IL-6, IL-8, MCP-1 and IL-10 could play a pivotal role in the acute phase of sepsis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-32275-8

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Changes in the levels of 11 cytokines and PAI-1 and in SOFA and DIC scores. (a) (A) Interleukin-1 beta (IL-1β), (B) interleukin-6 (IL-6), (C) interleukin-8 (IL-8), (D) interleukin-10 (IL-10), (E) monocyte chemotactic protein-1 (MCP-1), (F) plasminogen activator inhibitor-1 (PAI-1), (G) interleukin-12/23p40 (IL-12/IL-23p40), (H) interleukin-4 (IL-4), (I) interleukin-17A (IL-17A), (J) interferon-α (IFN-α), (K) interferon-γ (IFN-γ), and (L) tumour necrosis factor-α (TNF-α). The cytokine and PAI-1 values were transformed to common logarithm values to normalise the distribution of the data. All data are expressed as mean ± SD. Asterisks indicate a significant difference in cytokine and PAI-1 levels between control and septic patients on each day (P < 0.05). (b) Changes of (M) SOFA score, (N) JAAM score (O) and ISTH DIC score. The boxes indicate the lower and upper quartiles, the central line is the median, and the ends of the whiskers represent the maximum and minimum values. SOFA: Sequential Organ Failure Assessment; JAAM: Japanese Association for Acute Medicine; ISTH: International Society of Thrombosis and Haemostasis.
Figure 1 Changes in the levels of 11 cytokines and PAI-1 and in SOFA and DIC scores. (a) (A) Interleukin-1 beta (IL-1β), (B) interleukin-6 (IL-6), (C) interleukin-8 (IL-8), (D) interleukin-10 (IL-10), (E) monocyte chemotactic protein-1 (MCP-1), (F) plasminogen activator inhibitor-1 (PAI-1), (G) interleukin-12/23p40 (IL-12/IL-23p40), (H) interleukin-4 (IL-4), (I) interleukin-17A (IL-17A), (J) interferon-α (IFN-α), (K) interferon-γ (IFN-γ), and (L) tumour necrosis factor-α (TNF-α). The cytokine and PAI-1 values were transformed to common logarithm values to normalise the distribution of the data. All data are expressed as mean ± SD. Asterisks indicate a significant difference in cytokine and PAI-1 levels between control and septic patients on each day (P < 0.05). (b) Changes of (M) SOFA score, (N) JAAM score (O) and ISTH DIC score. The boxes indicate the lower and upper quartiles, the central line is the median, and the ends of the whiskers represent the maximum and minimum values. SOFA: Sequential Organ Failure Assessment; JAAM: Japanese Association for Acute Medicine; ISTH: International Society of Thrombosis and Haemostasis.CC BY · PubMed Central
Figure 2 Levels of cytokines and PAI-1 in critical ill patients and non-critical ill patients. (A) Interleukin-1 beta (IL-1β), (B) interleukin-6 (IL-6), (C) interleukin-8 (IL-8), (D) interleukin-10 (IL-10), (E) monocyte chemotactic protein-1 (MCP-1), and (F) plasminogen activator inhibitor-1 (PAI-1) levels on day 1 (critically ill patients and non-critically ill patients: n = 7 and n = 24), day 2 (n = 6 and n = 18) and day 4 (n = 4 and n = 18), respectively. The boxes indicate the lower and upper quartiles, the central line is the median, and the ends of the whiskers represent the maximum and minimum values. Asterisks indicate a significant difference between critically ill patients, non-critically ill patients and controls (P < 0.05).
Figure 2 Levels of cytokines and PAI-1 in critical ill patients and non-critical ill patients. (A) Interleukin-1 beta (IL-1β), (B) interleukin-6 (IL-6), (C) interleukin-8 (IL-8), (D) interleukin-10 (IL-10), (E) monocyte chemotactic protein-1 (MCP-1), and (F) plasminogen activator inhibitor-1 (PAI-1) levels on day 1 (critically ill patients and non-critically ill patients: n = 7 and n = 24), day 2 (n = 6 and n = 18) and day 4 (n = 4 and n = 18), respectively. The boxes indicate the lower and upper quartiles, the central line is the median, and the ends of the whiskers represent the maximum and minimum values. Asterisks indicate a significant difference between critically ill patients, non-critically ill patients and controls (P < 0.05).CC BY · PubMed Central
Figure 3 Hierarchical clustering and network visualisation. The cytokine and PAI-1 values were transformed to common logarithm values to normalise the distribution of the data. (A) Hierarchical clustering of Pearson’s correlations between cytokines and PAI-1. The outlined boxes show the common cytokine network in the acute phase of sepsis (days 1–4). (B) This network visualises the significant correlations of (A). The cytokines and PAI-1 with log2 fold change (i.e. average cytokine levels in sepsis patients/average cytokine levels in controls) > 1.5 were included. The size of each node was determined based on the log2 fold change. Red, yellow, and grey colours indicate a significant increase in the cytokines and PAI-1 levels between septic patients and controls, between critically ill patients and controls, and no difference between septic or critically ill patients and controls, respectively. Increased cytokines compared to those of the controls and the connections are shown to represent networks with major impact. IFN-α: interferon-α; IFN-γ: interferon-γ; IL-1β: interleukin-1 beta; IL-6: interleukin-6; IL-8: interleukin-8; IL-12/IL-23p40: interleukin-12/23p40; IL-17A: interleukin-17A; TNF-α: tumour necrosis factor-α; MCP-1: monocyte chemotactic protein-1; IL-4: interleukin-4; IL-10: interleukin-10; PAI-1: plasminogen activator inhibitor-1.
Figure 3 Hierarchical clustering and network visualisation. The cytokine and PAI-1 values were transformed to common logarithm values to normalise the distribution of the data. (A) Hierarchical clustering of Pearson’s correlations between cytokines and PAI-1. The outlined boxes show the common cytokine network in the acute phase of sepsis (days 1–4). (B) This network visualises the significant correlations of (A). The cytokines and PAI-1 with log2 fold change (i.e. average cytokine levels in sepsis patients/average cytokine levels in controls) > 1.5 were included. The size of each node was determined based on the log2 fold change. Red, yellow, and grey colours indicate a significant increase in the cytokines and PAI-1 levels between septic patients and controls, between critically ill patients and controls, and no difference between septic or critically ill patients and controls, respectively. Increased cytokines compared to those of the controls and the connections are shown to represent networks with major impact. IFN-α: interferon-α; IFN-γ: interferon-γ; IL-1β: interleukin-1 beta; IL-6: interleukin-6; IL-8: interleukin-8; IL-12/IL-23p40: interleukin-12/23p40; IL-17A: interleukin-17A; TNF-α: tumour necrosis factor-α; MCP-1: monocyte chemotactic protein-1; IL-4: interleukin-4; IL-10: interleukin-10; PAI-1: plasminogen activator inhibitor-1.CC BY · PubMed Central
Figure 4 Correlations between cytokines and PAI-1 and the combined scores and disease severities in the patients with sepsis. Correlations with (A) SOFA score, (B) JAAM score and (C) ISTH score. The red colour indicates a positive correlation, and the blue colour indicates a negative correlation. The P values in bold font indicate statistical significance. The levels of the 11 cytokines and PAI-1, which were transformed to common logarithm values, and the combined scores were used for analysis. SOFA: Sequential Organ Failure Assessment; JAAM: Japanese Association for Acute Medicine; ISTH: International Society of Thrombosis and Haemostasis; PAI-1: plasminogen activator inhibitor-1; IL-1β: interleukin-1 beta; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; MCP-1: monocyte chemotactic protein-1; IL-4: interleukin-4; IL-12/IL-23p40: interleukin-12/23p40; IL-17A: interleukin-17A; TNF-α: tumour necrosis factor-α; IFN-α: interferon-α; IFN-γ: interferon-γ; NA: not available. Combined scores A, B, C and D: combined scores of (IL-1β, IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1) and (IL-6, IL-8, MCP-1), respectively.
Figure 4 Correlations between cytokines and PAI-1 and the combined scores and disease severities in the patients with sepsis. Correlations with (A) SOFA score, (B) JAAM score and (C) ISTH score. The red colour indicates a positive correlation, and the blue colour indicates a negative correlation. The P values in bold font indicate statistical significance. The levels of the 11 cytokines and PAI-1, which were transformed to common logarithm values, and the combined scores were used for analysis. SOFA: Sequential Organ Failure Assessment; JAAM: Japanese Association for Acute Medicine; ISTH: International Society of Thrombosis and Haemostasis; PAI-1: plasminogen activator inhibitor-1; IL-1β: interleukin-1 beta; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; MCP-1: monocyte chemotactic protein-1; IL-4: interleukin-4; IL-12/IL-23p40: interleukin-12/23p40; IL-17A: interleukin-17A; TNF-α: tumour necrosis factor-α; IFN-α: interferon-α; IFN-γ: interferon-γ; NA: not available. Combined scores A, B, C and D: combined scores of (IL-1β, IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1) and (IL-6, IL-8, MCP-1), respectively.CC BY · PubMed Central
Figure 5 Cox proportional-hazards analysis with time-dependent covariates for survival in the patients with sepsis. The cytokine and PAI-1 values and the combined scores were measured during the acute phase (day 1, day 2 and day 4). The cytokine and PAI-1 values were transformed to common logarithm values to normalise the distribution of the data. The maximum values from day 1; those from day 2, i.e. the maximum values from day 1 or day 2; and those from day 4, i.e. the maximum values measured on day 1, day 2 or day 4, were used as time-dependent covariates. The hazard ratio is provided as Q1 to Q3. The values were adjusted by APACHE II score and SOFA score. APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; PAI-1: plasminogen activator inhibitor-1; IL-1β: interleukin-1 beta; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; MCP-1: monocyte chemotactic protein-1; IL-4: interleukin-4; IL-12/IL-23p40: interleukin-12/23p40; IL-17A: interleukin-17A; TNF-α: tumour necrosis factor-α; IFN-α: interferon-α; IFN-γ: interferon-γ; NA: not available. Combined scores A, B, C and D: combined scores of (IL-1β, IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1) and (IL-6, IL-8, MCP-1), respectively.
Figure 5 Cox proportional-hazards analysis with time-dependent covariates for survival in the patients with sepsis. The cytokine and PAI-1 values and the combined scores were measured during the acute phase (day 1, day 2 and day 4). The cytokine and PAI-1 values were transformed to common logarithm values to normalise the distribution of the data. The maximum values from day 1; those from day 2, i.e. the maximum values from day 1 or day 2; and those from day 4, i.e. the maximum values measured on day 1, day 2 or day 4, were used as time-dependent covariates. The hazard ratio is provided as Q1 to Q3. The values were adjusted by APACHE II score and SOFA score. APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; PAI-1: plasminogen activator inhibitor-1; IL-1β: interleukin-1 beta; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; MCP-1: monocyte chemotactic protein-1; IL-4: interleukin-4; IL-12/IL-23p40: interleukin-12/23p40; IL-17A: interleukin-17A; TNF-α: tumour necrosis factor-α; IFN-α: interferon-α; IFN-γ: interferon-γ; NA: not available. Combined scores A, B, C and D: combined scores of (IL-1β, IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1) and (IL-6, IL-8, MCP-1), respectively.CC BY · PubMed Central
Figure 6 ROC analysis using the cytokines and PAI-1 and the SOFA score in the patients with sepsis. The levels of the 11 cytokines and PAI-1, which were transformed to common logarithm values, and the combined scores were used for analysis. The AUC was calculated to evaluate the prognostic accuracy of each marker on day 1 (A,B). The AUC analysed by the SOFA score with each cytokine was compared to the AUC analysed by the SOFA score only. The P values indicate statistical significance. AUC: area under the ROC curve; ROC: receiver operating characteristic; SOFA: Sequential Organ Failure Assessment; IL-1β: Interleukin-1 beta; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; MCP-1: monocyte chemotactic protein-1; PAI-1: plasminogen activator inhibitor-1. Combined scores A, B, C and D: combined scores of (IL-1β, IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1) and (IL-6, IL-8, MCP-1), respectively.
Figure 6 ROC analysis using the cytokines and PAI-1 and the SOFA score in the patients with sepsis. The levels of the 11 cytokines and PAI-1, which were transformed to common logarithm values, and the combined scores were used for analysis. The AUC was calculated to evaluate the prognostic accuracy of each marker on day 1 (A,B). The AUC analysed by the SOFA score with each cytokine was compared to the AUC analysed by the SOFA score only. The P values indicate statistical significance. AUC: area under the ROC curve; ROC: receiver operating characteristic; SOFA: Sequential Organ Failure Assessment; IL-1β: Interleukin-1 beta; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; MCP-1: monocyte chemotactic protein-1; PAI-1: plasminogen activator inhibitor-1. Combined scores A, B, C and D: combined scores of (IL-1β, IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1, PAI-1), (IL-6, IL-8, IL-10, MCP-1) and (IL-6, IL-8, MCP-1), respectively.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Matsumoto, H., Ogura, H., Shimizu, K., Ikeda, M., Hirose, T., Matsuura, H., Kang, S., Takahashi, K., Tanaka, T., & Shimazu, T.
Affiliations
  • The University of Osaka (JP)
  • Osaka City University (JP)
Corresponding author
Matsumoto, Hisatake
ORCID
Venue
Scientific Reports
Publisher
Springer Science and Business Media LLC
Published
2018-09-18
Volume
8
Issue
1
Pages
13995-13995
ISSN
2045-2322 (ISSN-L)
DOI
10.1038/s41598-018-32275-8
PMC
PMC6143513
OpenAlex
W2891533504
Cited by
193
References
47
Citations by year
2026: 14 · 2025: 30 · 2024: 20 · 2023: 18 · 2022: 36 · 2021: 34 · 2020: 27 · 2019: 14
FWCI
14.63
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
A Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan.
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
sepsis, cytokine network, prognostic factors, interleukin-6, interleukin-8, MCP-1, IL-10, plasminogen activator inhibitor-1, SOFA score, disseminated intravascular coagulation, disease severity, network analysis
MeSH terms
Aged, Aged, 80 and over, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prognosis, Prospective Studies, ROC Curve, Severity of Illness Index, Biomarkers, Survival Rate, Case-Control Studies, Cytokines, Disease Progression, Sepsis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review